NCT04424368

Brief Summary

one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches and its usage for conducting patients, who had myocardial infraction and who has a very high risk of developing an unfavorable outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 9, 2021

Status Verified

August 1, 2021

Enrollment Period

3.2 years

First QC Date

June 5, 2020

Last Update Submit

November 6, 2021

Conditions

Keywords

myocardial infractionthe high level of potential adherence to treatmentpolymorphism of genesremote monitoring, prognosis

Outcome Measures

Primary Outcomes (5)

  • cardiovascular mortality

    the number of deaths from cardiovascular causes

    12 months

  • acute myocardial infarction

    incidence of acute myocardial infarction

    12 months

  • cerebral stroke

    incidence of cerebral stroke

    12 months

  • revascularization

    frequency of repeated revascularization of coronary arteries

    12 months

  • hospitalization

    frequency of hospitalization about the progression of coronary heart disease

    12 months

Study Arms (2)

The remote monitoring system

EXPERIMENTAL

A group of patients, who had myocardial infraction and who has a very high risk of developing an unfavorable prognosis, which are followed up in the local outpatient department according to existing clinical recommendations and using remote monitoring system.

Device: The remote monitoring system

Clinical recommendations

NO INTERVENTION

A group of patients, who had myocardial infraction and who has a very high risk of developing an unfavorable prognosis, which are followed up in the local outpatient department according to existing clinical recommendations.

Interventions

Usage of remote monitoring system

The remote monitoring system

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
  • The high level of adherence to treatment
  • Signed informed agreement

You may not qualify if:

  • Active cancer or remission period less than 5 years;
  • Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
  • Mental illnesses.
  • Alcohol and drug abuse
  • Patient's noncompliance, according to the researchers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RyazSMU

Ryazan, Russia

Location

MeSH Terms

Conditions

Myocardial InfarctionPatient Compliance

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Kristina Pereverzeva, MD, PhD

    RyazSMU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

October 3, 2018

Primary Completion

December 3, 2021

Study Completion

December 31, 2021

Last Updated

November 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations